Breaking News

GRAM Completes Successful FDA Inspection

Following eight day inspection, GRAM was found to be in compliance with cGMP, with no Form 483 observations issued

Grand River Aseptic Manufacturing, Inc. (GRAM) has announced the successful outcome of its most recent inspection by the FDA. Following the inspection, conducted over eight days at GRAM’s facility in Grand Rapids, Mich., GRAM was found to be in compliance with Current Good Manufacturing Practices (cGMP), with no Form 483 observations issued. “The outcome of our recent FDA inspection really underscores GRAM’s day-to-day commitment to quality excellence,” said Colleen Herczak, vice president...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters